Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out whether abacavir (Ziagen®) lowers the levels of
ribavirin (Ribapak®) in the body of persons taking these two drugs.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
GlaxoSmithKline University of Colorado, Denver University of Nebraska